NUTX · CIK 0001479681
What Nutex Health Inc. told the SEC could break it.
Nutex's disclosures cluster on a single vulnerability: its out-of-network model, which draws roughly 97% of revenue from insurance with no negotiated rates and leans on No Surprises Act arbitration to get paid. Two related risks compound it — since May 2024 one outside vendor, HaloMD, exclusively processes all of those arbitration-eligible claims (50-60% of the total), and that same vendor faces insurer lawsuits that could reach back into Nutex's revenue. The company also flagged short-seller reports that drove sharp single-day stock declines.
4 self-disclosed vulnerabilities, pulled from its own filings, each in the company’s words, with the source. This is the risk register almost nobody reads.
In its own words
What could break it.
Supplier concentration
- HaloMD exclusively handles all Nutex out-of-network arbitration (~50-60% of claims)high
Since May 2024 a single vendor, HaloMD, exclusively handles all of Nutex's out-of-network claims eligible for No Surprises Act arbitration (~50-60% of the Company's claims in 2025); this exclusive dependence concentrates a major revenue driver in one third-party processor.
“Since May 2024, HaloMD has handled, on an exclusive basis, all out-of-network claims made by Nutex that are eligible for arbitration under federal and state “no surprise” laws.”
SEC filing →As of 2026
Litigation
- HaloMD subject to health-insurer lawsuits that could impair Nutex revenuemedium
HaloMD — the exclusive processor of Nutex's arbitration claims — has been and may again be sued by health insurance providers, which could adversely affect Nutex's revenues, reputation, financial condition and stock price.
“HaloMD, has been, and may in the future be, subject to lawsuits filed by health insurance providers, which may have an adverse impact on our revenues, reputation, financial condition and the trading price of our common stock.”
SEC filing →As of 2026
Other disclosures
- short-seller attacks causing stock-price volatilitymedium
Nutex has been the target of short-seller reports (July 22 and November 25, 2025) making allegations that drove sharp stock declines (a 16.4% one-day drop on July 23, 2025), creating market-confusion and reputational risk.
“On July 22, 2025, a short seller report that contained various allegations against the Company was published, that had an adverse impact on the market price of our common stock.”
SEC filing →As of 2026
Regulatory & policy
- out-of-network model dependent on No Surprises Act arbitration; 97% insurance payer mixmedium
Nutex operates as an out-of-network provider with no negotiated insurer rates, deriving ~97% of revenue from insurance and relying on No Surprises Act federal/state arbitration for reimbursement; adverse NSA/IDR rulings (e.g., the June 2025 Fifth Circuit decision affecting revenue recognition) directly threaten revenue.
“We generally operate as an out-of-network provider and, as such, do not have negotiated reimbursement rates with insurance companies.”
SEC filing →As of 2026
The hidden graph
Who it depends on, and who depends on it.
Relationships surfaced from filings, including ones disclosed by the other side, which is how the non-obvious ones come to light.
Its suppliers
HaloMD
“Since May 2024, HaloMD has handled, on an exclusive basis, all out-of-network claims made by Nutex that are eligible for arbitration under federal and state “no surprise” laws. During the year ended December 31, 2025, HaloMD submitted approximately 50-60% of the Company's”
Cited →
In the MyPRIA app, this is checked against the companies you actually own.
← World Watch